title: Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up.
abstract: Women who seek an abortion are motivated to use contraceptive methods afterwards. Because the return of fertility after abortion is immediate, there is a need for effective and safe contraception promptly after the termination of pregnancy. A randomized trial of Mirena and NovaT intrauterine contraceptive devices inserted at the time of elective termination of pregnancy, duration no more than 12 weeks, is reported here. Women were randomized 2:1 resulting in 305 subjects with Mirena and 133 with NovaT as a segment of a larger study of 3000 women. In the Mirena group, two pregnancies at year 4 resulted in a final gross rate of 0.8 at 5 years, which was significantly (p < 0.0004) lower than the corresponding rate of 9.5 with NovaT. Terminations because of expulsion, bleeding problems, pain, pelvic inflammatory disease and other medical reasons were less common in the Mirena group, but not significantly different. The cumulative expulsion gross rate for NovaT at 5 years was 15.4 and for Mirena it was 10.5. Termination rates because of amenorrhea were low in both groups. It is concluded that both devices were well tolerated. Mirena was more effective and the rate of adverse events was lower than with NovaT. Special attention should be paid to the insertion procedure when carried out at the time of abortion.
authors.affiliation: Steroid Research Laboratory, Biochemistry, Institute of Biomedicine, Biomedicum, University of Helsinki, Helsinki, Finland. paivi.pakarinen@hus.fi
authors.forename: Päivi
authors.initials: P
authors.lastname: Pakarinen
authors.forename: Juhani
authors.initials: J
authors.lastname: Toivonen
authors.forename: Tapani
authors.initials: T
authors.lastname: Luukkainen
mesh_terms: D000028:Abortion, Induced; D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007433:Intrauterine Device Expulsion; D007435:Intrauterine Devices, Copper / Q000706:statistics & numerical data*; D016912:Levonorgestrel / Q000008:administration & dosage*; D010146:Pain / Q000209:etiology; D000292:Pelvic Inflammatory Disease / Q000209:etiology; D011247:Pregnancy; D014592:Uterine Hemorrhage / Q000209:etiology
chemical_list: D016912:Levonorgestrel